Safety of bronchoscopy in interstitial lung disease patients
Part of Lungs & breathing clinical trials.
This study watches to see if a lung procedure called bronchoscopy is safe for people with interstitial lung disease (a condition where lung tissue becomes scarred or inflamed). Researchers will track how patients do during and after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have suspected or confirmed interstitial lung disease (scarring or inflammation in the lungs)
- Your doctor has recommended bronchoscopy as part of your regular care
- You are able to understand and sign a consent form
- You do not have medical conditions that would make bronchoscopy too risky for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how safe a lung biopsy (a small sample taken with a needle) is for people with interstitial lung disease, a condition that causes scarring in the lungs. The goal is to see if the biopsy can be done with fewer risks when guided by ultrasound.
This study compares a robotic-assisted bronchoscope to a conventional one for performing a lung biopsy (cryobiopsy) in people with interstitial lung disease. The goal is to see which method is better at getting enough tissue for a diagnosis.
This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
This study follows patients with chronic lung scarring (fibrosing interstitial lung disease) who are in the intensive care unit for severe breathing failure. It aims to better understand their condition and care, which may help improve future treatments.
This study uses a lung wash (bronchoalveolar lavage) to look at the types of immune cells in the lungs of people with certain lung scarring diseases called interstitial lung diseases (ILD). It may help doctors better understand different ILD types and guide treatment.
Hear when a new Bronchoscopy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.